NSEOutcome of Board Meeting5d ago · 14 Aug 2026, 07:30 pm

Outcome of Board Meeting

Modi Naturals Limited · MODINATUR

✦ AI SummaryResults

Modi Naturals Limited has announced the outcome of its board meeting, where it approved the unaudited financial results for the quarter ended June 30, 2026. The results will be published in newspapers and uploaded on the company's website. The board meeting was held on August 14, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Outcome of Meeting of Board held on 14.08.2026

Attachments (1)

📄

MODINATURALS_14082026192845_Outcome_of_BM.pdf

pdf

Download →
View document text
14th August 2026 The Manager The Manager Corporate Relationship Department Listing Department BSE Limited National Stock Exchange of India Limited First Floor, New Trade Wing Rotunda Exchange Plaza, 5th Floor Plot No. C/1, ‘G’ Block, Building, Phiroze Jeejeebhoy Towers, Bandra- Kurla Complex Bandra, East Mumbai-400 Dalal Street, Fort Mumbai-400001 051 Scrip Code: 519003 Symbol : MODINATUR Dear Sir / Madam, Sub: Outcome of the Board Meeting held on 14.08.2026 Re: Submission of Unaudited Financial Results (Standalone and Consolidated) for the quarter ended 30th June 2026 Pursuant to Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI LODR Regulations”), we wish to inform you that the Board of Directors of the Company at its meeting held today, 14th August, 2026, has, inter alia, approved the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended 30th June, 2026, and took on record the limited review report of the Statutory Auditors of the Company thereon. As required under Regulation 33 of the SEBI LODR Regulations, we enclose herewith the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended 30th June, 2026, along with the limited review report thereon. The said results will be published in the newspapers as required under Regulations 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and will be uploaded on the website of the Company i.e., (www.modinarurals.com) The meeting of the Board of Directors of the Company commenced at 2:00 pm and concluded at 6:45 pm. This is for your kind information and records. Thanking you! Yours Faithfully, for MODI NATURALS LIMITED Rajan Kumar Singh Company Secretary & Compliance Officer Encl: as above B.Chhawchharia & Co. 5. 525, DLF TOWER B, JASOLA DISTRICT CENTRE, JASOLA, NEW DELHI 110025, INDIA Chartered Accountants TELEFAX (91-11) 4037 8600 @ Web : www.bcco.co.in Independent Auditor’s Review Report on the Quarterly Unaudited Consolidated Financial Results of the Company pursuant to the requirement of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended Review Report to The Board of Directors M/s MODI NATURALS LIMITED 1. We have reviewed the accompanying statement of unaudited consolidated financial results of M/s MODI NATURALS LIMITED("the Holding Company™) and its subsidiary (the Holding Company and its subsidiary together referred to as “the Group™) for the quarter ended June 30, 2026 being submitted by the Holding Company pursuant to the requirement of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. 2. This statement is the responsibility of the Holding Company’s Management and has been approved by the holding company’s Board of Directors, has been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standard 34, (IND AS 34) “Interim Financial Reporting”, specified under Section 133 of the Companies Act, 2013 as amended read with relevant rules issues thereunder and other accounting principles generally accepted in India. Our responsibility is to issue a report on these financial statements based on our review 3. We conducted our review in accordance with the Standard on Review Engagement (SRE) 2410, Review of interim Financial information performed by the Independent Auditors of the entity issued by the Institute of Chartered Accountants of India. This standard requires that we plan and perform the review to obtain moderate assurance as to whether the financial statements are free of material misstatement. A review is limited primarily to inquiries of company personnel and analytical procedures applied to financial data and thus provides less assurance than an audit. We have not performed an audit and accordingly, we do not express an audit opinion. 4. We also performed procedures in accordance with the SEBI Circular No. CIR/CFD/CMD/44/2019 dated 29th March, 2019 issued by the SEBI under regulation 33(8) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, to the extent applicable. KOLKATA | NEWDELHI | NAGPUR The Statement includes the results of following entity: © Wholly Owned Subsidiary: i. Modi Biotech Private Limited Based on our review conducted as above, nothing has come to our attention that causes us to believe that the accompanying statement of unaudited financial results prepared in accordance with applicable Indian accounting standards and other recognized accounting practices and policies has not disclosed the information required to be disclosed in terms of Regulations 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, including the manner in which it is to be disclosed, or that it contains any material misstatement. The review of audited consolidated quarterly and year-to-date financial results for the period ended March 31, 2026, included in the Statement was carried out and reported by M/s Doogar & Associates, previous auditor who have expressed unmodified conclusion vide their review report, which has been relied upon by us for the purpose of our review of the Statement. Our conclusion is not modified in respect of this matter. The review of unaudited consolidated quarterly and year-to-date financial results for the period ended June 30, 2025 and audit of consolidated financial results for the quarter and year ended March 31, 2026 included in the Statement was carried out and reported by M/s Doogar & Associates, previous auditor who had expressed unmodified conclusion vide their review report and unmodified opinion vide their audit report, respectively, whose reports have been furnished to us and which have been relied upon by us for the purpose of our review of the Statement. Our conclusion is not modified in respect of this matter. For B. Chhawchharia & Co. Chartered Accountants Firm Registration No: 305123E Bupize. Abhishek Gupta Partner Membership No.: 529082 Place: New Delhi Date:14™ August, 2026 UDIN: 26520 0 g XEZN LPI229 MODI NATURALS LIMITED Regd. & Corporate Office: D-54, 2nd Floor, Okhla Induatrial Area, Phase-I, New Delhi-110020 (CIN: L15142DL1974PLTCel0: 00117-341488999)99,, E-mail: cs.mnl@modinaturals.org, Website: www.modinaturals.com, Statement of Consolidated Un-Audited Financial Results for the Quarter and Year ended 30-06-2026 (X Lakhs, Unless Otherwise Stated) Consolidated articatars Quarter Ended Year Ended 30/06/2026 | 31/03/2026 | 30/06/2025 | 31/03/2026 (Unaudited) | _(Audited) | (Unaudited) | (Audited) 1 [Revenue from Operations — 15560.64 24307.51] 15502.66] 7191837 S . 3291 20.75] 3.70) 98.4() ] N o Total Income (1+11) 15527.73| 24328.26] _ 15506.58] _ 72016.72 IV |Expenses T (a) Cost of materials consumed_ 10325.13 19546.41 10082.5() 52712.27) (b) Purchases of stock-in-trade - 23581 337.95] 181.24 1924.1 gc,])dCsl::;fi:s!’{trlalld\l:x|(unes of finished goods, work-in-progress — (000.27) 135461 = (d) Employee benefits expense 816.3 1132.73 74535 3413.78) (e) Finance costs ) o 299.05 144,61 22586 7783 () Depreciation and amortisation expense 290.18 198.99) 199.48) 80117} (g) Other expenses - B ) 144673 1733.63 1373.73 6462.60) Total Expenses (1V) 13932.91] 22206.05| 1416279 6614891 v iteanmd tsax (II1-1V) 159482 212221 1343.79) 5867.61] VI_|Exceptional items 0.00 485.57] 0.00) 48557 VI [Profit before tax (V+VI) 1594.82 2607.78 1343.79 6353.38 (a) Current 27071 518.37] 177.54 1009.94) (b) Deferred Tax 73.99 122,09 117.00 315.09 IX_|Profit/ (Loss) for the period (VII - VIIT) 1250.12 1967.36) 1049.25 5028.35) X _|Other Comprehensive Income Items that will not be reclassified to profit or loss 6.19) 28,81, (1.65) 298¢ (ii). Income tax relatintgo items that will not be reclassified to profitor loss . Income tax relatintgo items that will be reclassified to profit [Showing first 8,000 characters — download PDF for full document]